Marijuana: what we know and don’t now
Marijuana and cannabis still rouse much stir. Many countries and US states have lifted the ban on cannabis use. But the effects on the human body and brain are still far from clear. Partly because marijuana is a poorly defined substance that contains many possibly psychoactive components. And partly because of a lack of appropriate
A solution to the Sargassum problem
Since 2011, the Caribbean is bothered by seaweed. Large quantities of Sargassum are washed up on the shores. There it rots, depleting the coastal waters from oxygen, releasing hydrogen sulphide and methane. And trapping marine life, coral reefs and fish. Apart from being an absolute nuisance, the seaweed is bad for tourism, on which many
Performance and sustainability, drivers of demand for biobased chemicals
‘Biobased materials and chemicals are driven by performance,’ we wrote in 2016. They do not compete primarily on cost, but on the new functionalities they offer. Now, in the middle of record low oil prices, this principle receives support from an article in Chemical and Engineering News, CEN. They highlight three companies whose biobased chemicals
The potential of bio waste in Europe
In Europe, just 16% of bio waste is processed to some form of useful application. Meaning: food and garden waste. An upcoming report by the Biobased Industries Consortium and Zero Waste Europe calculates the potential, and maps interesting and successful policies. Useful application of waste The Biobased Industries Consortium (BIC) is an association of European
Biomedicines are coming
The major pharmaceutical industry is going through a difficult time. Industry should find a new track. Biomedicines could open up a new chapter. This is the third of four articles on the pharmaceutical industry. Biomedicines, yes or no? For over 20 years, biotechnology and gene therapy have hold the promise of determining the future of
Has big pharma lost track?
Major pharmaceutical companies (big pharma) are having a difficult time. Shareholders complain about falling profit margins; governments, insurance companies and patients complain about sky-high medicine prices. Industry should find a new direction – but which one? This is the first of four articles about the pharmaceutical industry. Big pharma’s old model has become obsolete The
Traditional Chinese medicine as a source of innovation
Chemical and Engineering News recently ran an article that sheds light on the importance of traditional Chinese medicine for modern scientific development. Traditional treatments inspire the discovery of insecticides and antimalarial drugs. Useful symbiotic microorganisms The herb Stemona sessilifolia has been used in traditional Chinese medicine as an insecticide for hundreds of years. It moreover
Nebulised interferon as a COVID-19 medicine
In a small clinical study conducted in April and May 2020, British scientists investigated the effect of inhalation of nebulised interferon-beta-1a (SNG001) on the development of COVID-19 in patients. The results are encouraging and justify further research. Lung infections Being a 71-year-old asthmatic man, I have to take great care not to run into a
on: 27 December 2020